NovaBridge Biosciences (NBP) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 |
|---|
| Cash from Operations | -14.6M | 13.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.12B | 0 | -42.61M | -285.58M | -1.99B | -265.23M | -221.32M | -221.32M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | -664.93% | - | -164.33% | -1101.39% | -5663.19% | -755.07% | -2490.11% | -2490.11% |
| Operating CF Growth % | - | - | - | - | - | - | - | - | 100% | - | 100% | 100% | -6.52% | 100% | 80.75% | -29.03% | -295.76% | -13.91% | -26.54% | -26.54% |
| Net Income | -72.86M | -48.68M | -13.27M | -22.87M | -66.14M | -143.8M | 180.07M | 20.84M | -346.45M | -346.45M | -386.4M | -386.4M | -2.51B | -730.23M | -78.1M | -523.43M | -627.53M | -627.53M | -538.24M | -538.24M |
| Depreciation & Amortization | 216K | 1.54M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.14M | 0 | 3.6M | 16.64M | 9.15M | 9.15M | 6.77M | 6.77M |
| Stock-Based Compensation | 3.94M | 10.37M | 2.15M | 2.18M | 11.32M | 2.11M | 8.26M | -13.72M | 29.09M | 29.09M | 67.41M | 67.41M | 80.1M | 80.1M | 14.69M | 98.47M | 136.94M | 136.94M | 167.36M | 167.36M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 43.82M | 16.8K | 11.12M | 20.69M | 54.82M | 141.69M | -188.33M | -7.12M | 317.36M | 317.36M | 318.99M | 318.99M | 60.92M | 650.13M | 14.17M | 102.47M | -1.74B | 228.08M | 41.9M | 41.9M |
| Working Capital Changes | 10.28M | 49.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 235.16M | 0 | 3.02M | 20.27M | 235.16M | -11.87M | 100.88M | 100.88M |
| Change in Receivables | 0 | -10.26M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33.08M | 0 | -352.72K | -2.36M | 97.42M | -21.98M | 57.49M | 57.49M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27.24M | 0 | 2.03M | 13.62M | -27.24M | -13.62M | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 164.73M | 0 | 0 | 0 |
| Cash from Investing | 0 | -360.38K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 403.9M | 0 | 37.25M | 249.67M | -781.69M | -172.91M | -190.69M | -190.69M |
| Capital Expenditures | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -37.96M | 0 | -1.41M | -9.44M | -22.06M | -12.94M | -2.03M | -2.03M |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 11.91% | - | 5.43% | 36.4% | 62.8% | 36.83% | 22.85% | 22.85% |
| Acquisitions | 0 | -161 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -91.46M | 0 | 38.66M | 259.11M | -97.48M | -159.98M | -188.66M | -188.66M |
| Cash from Financing | -3.02M | 433.38M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.79B | 0 | 2.64M | 17.69M | -2.79B | 53.84M | 243.12M | 243.12M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 61.71M | 440.27M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -64.74M | -6.89M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.79B | 0 | 2.64M | 17.69M | -2.79B | 53.84M | 243.12M | 243.12M |
| Net Change in Cash | -17.43M | 446.12M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.39B | 0 | 13.97M | 93.63M | -5.44B | -413.21M | -204.36M | -204.36M |
| Free Cash Flow | -14.6M | 13.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.16B | 0 | -44.02M | -295.02M | -1.99B | -278.16M | -223.35M | -223.35M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | -676.84% | - | -169.76% | -1137.79% | -5668.98% | -791.89% | -2512.96% | -2512.96% |
| FCF Growth % | - | - | - | - | - | - | - | - | 100% | - | 100% | 100% | -8.32% | 100% | 80.29% | -32.09% | -296.59% | -17.14% | -27.66% | -27.66% |
| FCF per Share | -0.29 | 0.30 | - | - | - | - | - | - | - | - | - | - | -26.03 | - | -0.54 | -3.59 | -25.36 | -3.54 | -3.04 | -3.04 |
| FCF Conversion (FCF/Net Income) | 3.32x | -1.93x | - | - | - | - | - | - | - | - | - | - | 2.90x | - | 0.08x | 0.55x | 3.17x | 0.42x | 0.41x | 0.41x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |